P3 Health Ownership
| PIII Stock | USD 0.17 0.01 6.25% |
PIII |
PIII Stock Ownership Analysis
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.23. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. P3 Health Partners recorded a loss per share of 0.87. The entity had not issued any dividends in recent years. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. P3 Health operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 523 people. To find out more about P3 Health Partners contact FACEP FACP at 702 910 3950 or learn more at https://p3hp.org.Besides selling stocks to institutional investors, P3 Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different P3 Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align P3 Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
P3 Health Quarterly Liabilities And Stockholders Equity |
|
About 62.0% of P3 Health Partners are currently held by insiders. Unlike P3 Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against P3 Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of P3 Health's insider trades
PIII Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as P3 Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading P3 Health Partners backward and forwards among themselves. P3 Health's institutional investor refers to the entity that pools money to purchase P3 Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Cresset Asset Management, Llc | 2024-12-31 | 150 K | Warberg Asset Management Llc | 2024-12-31 | 145.3 K | Blair William & Co | 2024-12-31 | 125.8 K | Moneta Group Investment Advisors Inc | 2024-12-31 | 112.8 K | State Street Corp | 2024-12-31 | 101.4 K | Northern Trust Corp | 2024-12-31 | 100 K | Welch Capital Partners Llc | 2024-12-31 | 90 K | Prudential Investment Management Inc | 2024-09-30 | 88 K | Hrt Financial Llc | 2024-12-31 | 71.3 K | Alyeska Investment Group, L.p. | 2024-12-31 | 11.9 M | Vanguard Group Inc | 2024-12-31 | 1.8 M |
P3 Health Partners Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific P3 Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on P3 Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases P3 Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
P3 Health Outstanding Bonds
P3 Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. P3 Health Partners uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PIII bonds can be classified according to their maturity, which is the date when P3 Health Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ES 515 15 JAN 53 Corp BondUS744482BP42 | View | |
| PUBLIC SVC O Corp BondUS744448CN95 | View | |
| PUBLIC SVC O Corp BondUS744448CP44 | View | |
| PUBLIC SVC O Corp BondUS744448CQ27 | View | |
| US744448CR00 Corp BondUS744448CR00 | View | |
| US744448CS82 Corp BondUS744448CS82 | View | |
| US744448CT65 Corp BondUS744448CT65 | View |
Currently Active Assets on Macroaxis
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.87) | Revenue Per Share | Quarterly Revenue Growth 0.256 | Return On Assets | Return On Equity |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.